Regencell Bioscience (RGC) has had the highest return since 2025 by a US stock in the Nasdaq Composite (IXIC), returning 24,623.1%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 24,623.05% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
FiEE (FIEE) | 1,679.82% |
Abivax SA American Depositary Shares (ABVX) | 1,545.03% |
Oncology Institute (TOI) | 1,249.67% |
Hycroft Mining (HYMC) | 1,164.16% |
Santech (STEC) | 1,005.26% |
DeFi Development (DFDV) | 978.91% |
Sandisk (SNDK) | 897.23% |
Abits (ABTS) | 829.47% |
AXT (AXTI) | 808.56% |
XMax (XWIN) | 796.97% |
Cidara Therapeutics (CDTX) | 716.6% |
Celcuity LLC (CELC) | 694.4% |
Relmada Therapeutics (RLMD) | 686.43% |
Palvella Therapeutics (PVLA) | 678.9% |
Diginex Limited Ordinary Shares (DGNX) | 660.56% |
Aimei Health Technology Co, Ltd Ordinary Share (AFJK) | 625.35% |
Terns Pharmaceuticals (TERN) | 579.43% |
Almonty Industries Inc Common Shares (ALM) | 576.39% |
Haoxi Health Technology Limited Class A Ordinary Shares (HAO) | 572.83% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 566.11% |
Newegg Commerce (NEGG) | 563.75% |
Nanobiotix (NBTX) | 554.98% |
Charming Medical Limited Class A Ordinary Shares (MCTA) | 539.54% |
